5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with afimoxifene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berns, A; Bex, A; Horenblas, S; Vooijs, M | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and afimoxifene
Article | Year |
---|---|
Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.
Topics: Animals; beta-Galactosidase; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Antagonists; Galactosides; Gene Targeting; Genes, Reporter; Genes, Tumor Suppressor; Indoles; Integrases; Mice; Mice, Transgenic; Mutagenesis, Insertional; Mutation; Proteins; Receptors, Estrogen; Recombination, Genetic; RNA, Untranslated; Tamoxifen; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium; Viral Proteins | 2002 |